|
|
|
| An analysis on the effect of community management of multi-drug resistant pulmonary tuberculosis patients on treatment outcome |
| ZHOU Lin, CHAI Cheng-liang,CHEN Song-hua, CHEN Bin, ZHANG Yu,PENG Ying, WANG Fei, ZHANG Ming-wu, WANG Xiao-meng
|
| The Center for Disease Control and Prevention of Zhejiang Province, Hangzhou, Zhejiang, 310051,China |
|
|
|
|
Abstract Objective To explore the outcome and its influencing factors of the Multi-drug resistant tuberculosis(MDR-TB) patients with community management, and to provide the scientific basis for the further implementation of the community management of MDR-TB patients. Methods Retrospective study was conducted on MDR-TB patientsdiagnosed and treated with MDR-TB from January 2009 to June 2012 and the patients' willingness and influence factors of outcome in community management were analyzed. Results 220 MDR-TB patients were under community management and the cute rate was 65.91%.The cure rate of patients withdegree in college or above ,occupation for workers, new type of patients, patients with no adverse reactions during drug injection therapy was relatively high.The cure rate of the patients who injectedin home(86.67%) was higher than who injected in community(68.15%) and others(54.84%). The cure rate of the patients whose injection distance from home≤5 km(67.74%) was higher than whose injection distance from home >5 km(36.36%). The cure rate of the patients with community doctor/nurse follow-up management(70.39%) was higher than those who without community doctor/nurse follow-up management(55.88%). Through the analysis of needs for the community management, the results showed that 65.91% of the patients were willing to accept the injection in the community, and 94.09% patients chose medication at home.Conclusion The cute rate of MDR-TB patients should be improved in community management. In the future, we should pay more attention to the patients' needs in the development of community management for MDR-TB patientsaccording to the actual situation, and to further strengthenthe psychological support andcommunitycare for MDR-TB patients.
|
|
Received: 30 May 2016
Published: 21 November 2017
|
|
|
|
|
|
[1] 陆峰,马俊锋,符剑.76例耐多药肺结核患者治疗转归队列分析[J].江苏预防医学,2015,25(2)53-54.
[2]王倪,王黎霞,朱坤,等.耐多药结核病患者管理模式的系统综述[J].中国防痨杂志,2012,34(9)596-600.
[3]洪建军,路丽苹,金晓萍.耐多药肺结核患者社区管理的探讨[J].中国社区医师(医学专业),2012,14(14)389-390.
[4]孔雯,刘巧,陆伟,等.标准化耐多药肺结核化疗方案的不良反应及治疗转归情况分析[J].中华疾病控制杂志,2014,18(7)610-612.
[5]车洋,于梅,平国华,等.宁波地区2010—2011年结核病耐药监测结果及影响因素分析[J].中国卫生检验杂志,2013,23(2)495-497.
[6]杨华.结核病患者化疗依从性及影响因素分析[J].医学信息,2010,23(10)3577-3578.
[7]DROBAC P C, MUKHERJEE J S, JOSEPH J K, et al.
Community-based therapy for children with multidrug-resistant tuberculosis[J]. Pediatrics, 2006, 117(6)2022-2029.
[8]叶浩森,董晓欣,候万里.我国社区卫生服务机构参与中国督导短程化疗策略实施现状及对策[J].医学与社会,2013,26(8)12-14.
[9]王丽.结核病患者社区管理需求调查[J].浙江预防医学,2013,25(5)80-82.
[10]汪依帆,严非,吴来娃.上海市肺结核患者对督导访视的满意度及需求分析[J].中国初级卫生保健,2013,27(8)73-75.
[11]孙强,闫赟,边学峰,等.耐多药肺结核患者医疗费用及经济负担分析[J].中国卫生经济,2011,30(1)33-35.
[12]彭颖,陈松华,钟节鸣,等.耐多药肺结核患者未纳入诊治管理的原因分析[J].浙江预防医学,2014,26(3)272-274.
[13]王黎霞,徐彩虹,陈明亭,等.我国开展耐多药肺结核诊疗管理的可行性分析[J].中国卫生资源,2012,15(4)325-328.
|
|
|
|
